Medius Holdings Co., Ltd. (3154) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medius Holdings Co., Ltd. (3154:JPX), powered by AI.

Current Price
¥855
P/E Ratio
13.8
Market Cap
19.0B
Sector
Healthcare
What is the Medius Holdings Co., Ltd. stock price forecast?

Medius Holdings Co., Ltd. is currently trading at ¥855. View real-time AI analysis on Alpha Lenz.

What is Medius Holdings Co., Ltd. insider trading activity?

View the latest insider trading data for Medius Holdings Co., Ltd. on Alpha Lenz.

What is Medius Holdings Co., Ltd.'s P/E ratio?

Medius Holdings Co., Ltd.'s P/E ratio is 13.8.

Medius Holdings Co., Ltd.

JPX · 3154
¥855+0(+0.00%)Market closedJPX regular session 09:00–15:00 JST
Ask about Medius Holdings Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Medius Holdings Co., Ltd. trades at a P/E of 13.8 (undervalued) with modest ROE of 6.8%.

Ask for details

Company Overview

Medius Holdings Co., Ltd. is a Japanese company primarily engaged in the manufacture and wholesale distribution of health and wellness products. Its primary function is to develop and supply a diverse range of healthcare and fitness equipment, nutritional supplements, and wellness-related goods, catering to increasing consumer demand for health-conscious living. Medius Holdings plays a significant role in the health and wellness industry, impacting sectors such as medical devices, personal health care, and rehabilitation services. The company is known for its innovation and quality, ensuring that its products meet stringent industry standards, thereby gaining trust among its clientele, which includes both individual consumers and healthcare institutions. In the financial market, Medius Holdings Co., Ltd. holds a position as a key player within the health consumer goods sector in Japan, reflecting trends of an aging population and rising lifestyle-related health concerns. Consequently, Medius Holdings is influential in shaping how healthcare solutions are accessed and utilized across various communities.

CEOMr. Yasuhiko Ikeya
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees2,614

Company Statistics

FY 2025

Profile

¥18,993,517,200Market Cap
¥288,689,338,000Revenue
0.00Shares Out
2,614Employees

Margins

11.93%Gross
1.66%EBITDA
0.65%Operating
0.83%Pre-Tax
0.48%Net

Valuation

13.81P/E
0.93P/B
0.07EV/Sales
5.40EV/EBITDA
3.84P/FCF

Growth (CAGR)

8.41%Rev 3Yr
6.53%Rev 5Yr
-6.13%Op Inc 3Yr
11.26%Op Inc 5Yr
-9.70%Net Inc 3Yr
7.65%Net Inc 5Yr

Returns

1.21%ROA
6.84%ROE
2.25%ROIC

Financial Health

¥14,333,767,000Cash & Cash Equivalents
¥78,213,085,000Net Debt
451.93%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medius Holdings Co., Ltd. (ticker: 3154) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 2,614 employees. Market cap is $19.0B.

The current price is 855 with a P/E ratio of 13.81x and P/B of 0.93x.

ROE is 6.84% and operating margin is 0.65%. Annual revenue is $288.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medius Holdings Co., Ltd. (3154) Stock Forecast 2026 ¥855 — Price, Financials & Analyst Targets | Alpha Lenz